Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famciclovir Pediatric Formulation PK and Safety in Children with Herpes Simplex
NCT00098059Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of famciclovir in herpes simplex (HSV), sponsored by Novartis. Started Feb 2005; status: completed.
02
Drugs
famciclovir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on NCT00098059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098059.